Latest News
Team8: New parental control for healthy children
TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Team8 is an universe & Operating Systems for kids (6-12 years old). Give a new life to any Android phone (old or new) and secure it for kids combining Fun, Health, Education & Security. Kids can create and manage their own super-hero (name, costume, abilities...
Thunes Partners with the World Economic Forum to Power Innovation in Payments Infrastructure
SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- Thunes
Tencent Music Entertainment Group Announces Management and Director Responsibility Changes
SHENZHEN, China, Jan. 10, 2022 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME), the leading online music and audio entertainment platform inChina, today announced that Mr. Dennis Tak Yeung Hau has decided to resign from his position for personal reasons, ef...
Microland Has Earned the Microsoft Azure Virtual Desktop Advanced Specialization
This specialization demonstrates our expertise in assessment, design,
implementation, and optimization of virtual desktop infrastructure in Azure
ATLANTA, BENGALURU, India and LONDON, Jan. 11, 2022 /PRNewswire/ -- Microland
Colt Data Centre Services set for major growth spur, securing ten new sites across Europe & APAC
LONDON, Jan. 11, 2022 /PRNewswire/ -- Colt Data Centre Services
Court Decision: Rejecting All Claims from Delta due to No Infringement made by Appotronics
SHENZHEN, China, Jan. 10, 2022 /PRNewswire/ -- Appotronics (688007.SH) announced onJanuary 6 that, according to two civil judgments (Case No. (2019) Jing73 Min Chu No. 1275 and Case No. (2019) Jing73 Min Chu No. 1276) from Beijing Intellectual Property Court received by Appotronics, it was decide...
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy
SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- MicroStrategy
Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod
* Circle HealthPod detects >99.9% of known COVID-19 strains, including the Omicron variant, in approximately 20 minutes * With technology developed at the University of Oxford, the Circle HealthPod is a CE-IVD marked rapid detection system with 98.4% molecular accuracy * Frequent testing wit...
vivo Strengthens its Global Presence with User-oriented Innovation and Strategic Partnerships Designed to Inspire Joy
SHENZHEN, China, Jan. 11, 2022 /PRNewswire/ -- Global smartphone maker vivo has concluded an exceptional year, redoubling its efforts to deliver exciting new products and experiences to consumers around the world. In 2021, driven by its user-centered innovation strategy, vivo successfully launche...
Newgen Secures a Patent for Centralized Controlled Printing and Administration
- Patent to help enterprises in optimizing cost, and enabling anytime anywhere,
secure, green printing
SYDNEY, Jan. 11, 2022 /PRNewswire/ -- Newgen Software, a global provider of
low code digital transformation platform
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication
HANGZHOU, China and SHAOXING, China, Jan. 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC42 for chronic hepatitis B (CHB) indication. The Phase II clinical trial (ClinicalTrials.gov Identifier: NCT051...
Kognitiv Corporation promotes Peter Menges to EVP and Chief Commercial Officer
Seasoned executive brings Commercial focus to accelerate aggressive global growth TORONTO, Jan. 11, 2022 /PRNewswire/ -- Kognitiv Corporation, a global leader in the rapidly expanding market for collaborative commerce, announces the promotion ofPeter Menges to the role of EVP and Chief Commercia...
Proofpoint Completes the Acquisition of Dathena; Strengthens Enterprise Information Protection Offering
SUNNYVALE, Calif., Jan. 11, 2022 /PRNewswire/ -- Proofpoint, Inc.
Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand
TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...
Dr. Ivan Puah Highlights The Significant Impact Of Covid That Changes Our Priority In Life
SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- The current pandemic has raised more awareness of the importance of health and better care of oneself. Dr.Ivan Puah, Medical Director at Amaris B. Clinic shares how people's lifestyles and priorities have changed since Covid-19 started. 01. Losing we...
Shopless: Predictions for the New Zealand Job Market in 2022
WELLINGTON, New Zealand, Jan. 11, 2022 /PRNewswire/ -- The future's looking bright for New Zealand job seekers in 2022. With the idea of "The Great resignation" being floated andNew Zealand moving to the traffic light system, what are the predictions for the job market as a whole? How is 2022 exp...
Constant Contact Agrees to Acquire Vision6
WALTHAM, Mass. and BRISBANE, Australia, Jan. 11, 2022 /PRNewswire/ -- Constant
Contact
OneSmart International Education Group Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- OneSmart International Education Group Limited ("OneSmart" or the "Company") (NYSE: ONE) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual a...
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
SEATTLE and SAN FRANCISCO and SAN JOSE, Calif. and NANJING, China and SUZHOU, China andSHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage ...
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00